2. Academic Validation
  3. Acute pancreatitis: recent advances through randomised trials

Acute pancreatitis: recent advances through randomised trials

  • Gut. 2017 Nov;66(11):2024-2032. doi: 10.1136/gutjnl-2016-313595.
Sven M van Dijk 1,  Nora D L Hallensleben 2,  Hjalmar C van Santvoort 3,  Paul Fockens 4,  Harry van Goor 5,  Marco J Bruno 2,  Marc G Besselink 1,  Dutch Pancreatitis Study Group
Affiliations

Affiliations

  • 1 Department of Surgery, Amsterdam Gastroenterology and Metabolism, Academic Medical Center, Amsterdam, The Netherlands.
  • 2 Department of Gastroenterology & Hepatology, Erasmus University Medical Center, Rotterdam, The Netherlands.
  • 3 Department of Surgery, St. Antonius Hospital, Nieuwegein, The Netherlands.
  • 4 Department of Gastroenterology & Hepatology, Amsterdam Gastroenterology and Metabolism, Academic Medical Center, Amsterdam, The Netherlands.
  • 5 Department of Surgery, Radboud University Medical Center, Nijmegen, The Netherlands.
PMID: 28838972 DOI: 10.1136/gutjnl-2016-313595
Abstract

Acute pancreatitis is one of the most common GI conditions requiring acute hospitalisation and has a rising incidence. In recent years, important insights on the management of acute pancreatitis have been obtained through numerous randomised controlled trials. Based on this evidence, the treatment of acute pancreatitis has gradually developed towards a tailored, multidisciplinary effort, with distinctive roles for gastroenterologists, radiologists and surgeons. This review summarises how to diagnose, classify and manage patients with acute pancreatitis, emphasising the evidence obtained through randomised controlled trials.

Keywords

acute pancreatitis; classification; diagnosis; review; treatment.

Figures